GEHC GE HealthCare Technologies Inc.
Company Analysis
Latest News
GE HealthCare to Acquire Sofie for $945 Million, Adding 15 U.S. Sites
GE HealthCare has agreed to acquire Sofie Biosciences for $945 million in an all-cash deal. The acquisition will strengthen GE HealthCare’s Pharmaceutical...
Needham Bets GE HealthCare Is a Turnaround Story — But Can a Battered Stock Really Rally 43%?
Shares of GE HealthCare surged +12.7% to $74.67 after Needham analyst David Saxon initiated coverage with a Buy rating and a $93 price target, suggesting 43%...
🟢 GE HealthCare is trading 12.68% up in after-hours trading after Needham initiated Buy-rated coverage
GE HealthCare is trading at $74.67, up 12.68%, after Needham initiated coverage with a Buy rating. - Needham set a $93 price target, implying 43% upside from...
🟢 GE HealthCare is trading 8.2% up in after-hours trading with no verified company-specific announcement
GE HealthCare is trading at $69.39, up +8.20%, with no verified company-specific announcement dated September 18, 2026 explaining the after-hours surge. -...
GE HealthCare nears $1B Sofie Biosciences deal, boosting cancer imaging
GE HealthCare Technologies is in advanced negotiations to acquire radiopharmaceutical developer Sofie Biosciences for approximately $1 billion. The companies...
Activist Nelson Peltz's Trian Fund Boosts GE HealthCare Stake to $197.5 Million
Activist investor Nelson Peltz's Trian Fund Management dramatically increased its investment in GE HealthCare during the second quarter of 2026. The firm's...
Trian Fund Management Builds GE HealthCare Stake, Trims Janus Henderson
Nelson Peltz's Trian Fund Management reported a $4.23 billion portfolio in its Q2 2026 13F filing, which reflects holdings as of June 30, 2026. The activist...
Leon Cooperman Nearly Doubles Stake in GE HealthCare (GEHC)
In a recent 13F filing from August 14, 2026, veteran investor Leon Cooperman revealed a significant increase in his position in GE HealthCare Technologies. The...
Leon Cooperman's Omega bets big on new GPGI position, trims SUN
Leon Cooperman's Omega Advisors revealed a significant portfolio shift in its latest 13F filing for the second quarter of 2026. The firm's total portfolio...
GE HealthCare Appoints William K. Grogan as New Chief Financial Officer
GE HealthCare Technologies Inc. (GEHC) has appointed William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. Mr. Grogan joins from...
🔴 GE HealthCare is trading 17% down in after-hours trading with no confirmed explanation
GE HealthCare is trading at $61.41, down 16.78% after closing at $73.79 on August 13, 2026; available coverage did not identify a new earnings release,...
🔴 GE HealthCare is trading 4.2% down today as post-earnings gains reverse amid broader healthcare weakness
GE HealthCare is trading at $68.75 (-4.19%) as the stock reverses its post-earnings jump from July 29 amid a broader decline in the healthcare sector. • The...
🟢 GE HealthCare is trading 10.1% up today after Q2 earnings beat and record organic orders
GE HealthCare is trading 10.1% up at $70.61 after reporting a second-quarter 2026 earnings beat and record organic orders growth. • The company posted $5.3...
🟢 GE HealthCare is trading 8.4% up today after Q2 earnings beat and reaffirmed guidance
GE HealthCare is trading 8.4% up at $69.51 after reporting better-than-expected second-quarter 2026 results, including higher profit and strong order...
GE HealthCare's Blowout Quarter Sends Shares Soaring 12% — But Can a Record Backlog Outrun a CFO Exit and Margin Questions?
Shares surged as GE HealthCare delivered a Q2 that crushed expectations on nearly every front, posting the kind of orders growth that suggests hospitals aren't...
🟢 GE HealthCare is trading 12.3% up today after Q2 earnings beat and record organic orders growth
GE HealthCare is trading 12.3% up at $72.00 in pre-market trading after reporting better-than-expected second-quarter 2026 results and reaffirming its...
GE HealthCare's second quarter revenue of $5.3B beats estimates, driven by record orders while the company reaffirms its 2026 outlook.
GE HealthCare reported second quarter 2026 revenue of $5.3 billion, an increase of 5.7% year-over-year, with organic revenue growing 3.5%. Diluted EPS was...
🟢 GE HealthCare is trading 6% up today after reaffirming its positive Q2 outlook and preliminary results
GE HealthCare is trading approximately 6% higher at $67.94 in pre-market trading after reaffirming its positive second-quarter outlook and preliminary...
🟢 GE HealthCare is trading 4.3% up today as healthcare stocks rally on sector rotation
GE HealthCare is trading at $63.75 (+4.30%) as healthcare stocks rally and investors rotate into the sector. • The move is primarily driven by the broader...
GE HealthCare Technologies Inc. Q2 2026 Earnings Preview: What Analysts Expect on July 29, 2026
Wall Street expects GE HealthCare Technologies to report Q2 2026 revenue of $4.96 billion and earnings per share of $1.04, with the stock trading at $82.45...